GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CB Scientific Inc (OTCPK:CBSC) » Definitions » Valuation Rank

CB Scientific (CB Scientific) Valuation Rank


View and export this data going back to . Start your Free Trial

What is CB Scientific Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

CB Scientific Valuation Rank Related Terms

Thank you for viewing the detailed overview of CB Scientific's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

CB Scientific (CB Scientific) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CB Scientific Inc (OTCPK:CBSC) » Definitions » Valuation Rank
Comparable Companies
GCTK POAI ECIA RSCF NSTGQ AVGR NXGL MBOT IMTH STSS ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD OCSE:COLO B TSE:4543 WST XSWX:STMN
Traded in Other Exchanges
N/A
Address
10845 Griffith Peak Drive, Suite 200, Las Vegas, NV, USA, 89135
Website
https://www.cbscientificinc.com
CB Scientific Inc through its U.S. and international subsidiaries provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. The FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.